'Triple Therapy' Raises Bleed Risk After PCI for MI: Study

Regardless of P2Y12 receptor inhibitor used, the risk of bleeding complications went up by adding an oral anticoagulant to dual-antiplatelet therapy—maybe more so with one particular antiplatelet.